U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

Name: U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021
Uploaded: 2020-07-07T16:07:13+00:00
Duration: P80S
Description: At $1.6 billion, Novavax receives the largest amount the Trump administration has awarded to a company to manufacture millions of doses of a coronavirus vaccine

Credit: Veuer

Duration: 01:20s 07 Jul 2020 0 shares 1 views

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

At $1.6 billion, Novavax receives the largest amount the Trump administration has awarded to a company to manufacture millions of doses of a coronavirus vaccine set to be delivered by January.

Veuer’s Justin Kircher has more.

U.S. Gives $1.6B to Novavax to Deliver 100M Doses of Potential COVID-19 Vaccine by 2021

You might like